Lemtrada® (Alemtuzumab) is a medication used to treat adults with relapsing forms of multiple sclerosis (MS).
Lemtrada® is manufactured by Sanofi.
Administration and Dosage:
Administration of LEMTRADA® is intravenously infused over 4 hours for a 2 or more treatment course. First course consists of 12mg/ day for 5 consecutive days followed by 12mg/day on 3 consecutive days 12 months after the first course.
Common Side Effects:
The more common side effects of LEMTRADA® include serious autoimmune problems, serious infusion reactions, certain cancers, and stroke and tears in your arteries that supply blood to your brain (carotid and vertebral arteries).
More Information:
Please read the full Prescribing Information and Medication Guide for LEMTRADA® and discuss any questions you have with your doctor.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
Indication:
Lemtrada® is indicated to treat:
- Forms of Relapsing Multiple Sclerosis
